The outcomes measured were as follows : glycosylated hemoglobin ( HbA@c ) , glycemic variability ( GV ; assessed by @-h continuous glucose monitoring ) , antiglycemic medication changes ( antiglycemic medication effects score -LSB- MES -RSB- ) , and blood lipids and pressure .